Characterization of Claudin-Low Breast Cancer Cells from Mice
Author Information
Author(s): Campbell Craig I, Thompson Devan E, Siwicky Megan D, Moorehead Roger A
Primary Institution: University of Guelph
Hypothesis
Can murine mammary tumor cells with a claudin-low genotype provide insights into the claudin-low breast cancer subtype?
Conclusion
Mammary tumor cells from MTB-IGFIR transgenic mice can serve as effective models for studying claudin-low breast cancer.
Supporting Evidence
- The RM11A and RJ348 cells express high levels of mesenchymal genes and low levels of E-cadherin.
- These cells are highly tumorigenic when reintroduced into the mammary fat pad of mice.
- Claudin-low tumors have a reported prevalence of 7-14% and poor prognosis.
Takeaway
Scientists studied special cancer cells from mice to learn more about a type of breast cancer that is hard to treat.
Methodology
Cell lines were derived from MTB-IGFIR transgenic mice and characterized using gene expression analysis and tumor formation assays.
Limitations
The study primarily focuses on murine models, which may not fully replicate human disease.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website